Efficacy and safety of thoracic radiotherapy in extensive-stage small-cell lung cancer patients receiving first-line immunotherapy plus chemotherapy: a propensity score matched multicentre retrospective analysis
Platinum-etoposide chemotherapy combined with immune checkpoint inhibitors (ICIs) has been recommended as the first-line standard treatment for extensive-stage small-cell lung cancer (ES-SCLC). However, the ef...
Source: Radiation Oncology - Category: Cancer & Oncology Authors: Yueyuan Yao, Butuo Li, Ruiting Song, Linlin Yang, Bing Zou and Linlin Wang Tags: Research Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Immunotherapy | Lung Cancer | Small Cell Lung Cancer